New draft guidance issued by the FDA is intended to help device manufacturers meet their obligation to notify the agency when the supply of their products may be disrupted during or in advance of a public health emergency. The agency said that the draft guidance, meant to assist stakeholders “outside of the COVID-19 public health emergency,” will serve as the baseline for prov... Read More